A recent study demonstrated elevated levels of receptor of advanced glycation end products (RAGE) and advanced glycation end products (AGE) in CF patients with CFRD compared to CF patients without CFRD and healthy controls [33]. The gene discussed is AGER; the disease is cystic fibrosis-related diabetes.